Neurocognitive function of patients with severe combined immunodeficiency

Immunology and Allergy Clinics of North America
Ami J Shah, Donald B Kohn

Abstract

Hematopoietic stem cell transplantation (HSCT) has offered a curative approach for treating patients with severe combined immunodeficiency (SCID). However, HSCT may have long-term effects on some of these patients. This article reviews the literature regarding long-term neurocognitive function of patients who have received HSCT for SCID, including the effect of disease-specific characteristics, psychosocial factors, being a chronically ill child, and transplant-related factors.

References

Jan 1, 1991·Journal of Inherited Metabolic Disease·E TakedaM Miyao
Nov 1, 1988·Journal of Child Psychology and Psychiatry, and Allied Disciplines·P CousensM Stevens
Aug 14, 1980·The New England Journal of Medicine·R HirschhornL T Taft
Mar 2, 1997·Bone Marrow Transplantation·J H KramerM J Cowan
Feb 18, 1999·The New England Journal of Medicine·R H BuckleyF E Ward
Dec 26, 2001·Annual Review of Psychology·Robert H Bradley, Robert F Corwyn
Feb 5, 2004·The Journal of Pediatrics·Wendy Albuquerque, Hubert B Gaspar
May 12, 2006·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alessandra MariniUlrich R Hengge
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sean PhippsMaggi Dunavant

❮ Previous
Next ❯

Citations

Nov 19, 2011·Pediatric Transplantation·Laura DinardoKathleen E Sullivan
Mar 31, 2015·Current Pediatrics Reports·Justin T WahlstromMorton J Cowan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.